Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data.

France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US, saying it intends to spend "at least $20 billion" there by the ...

BOSTON, MA – Stanford professor, physician, and bestselling author Abraham Verghese began his address to the Class of 2025 by reflecting on his roots — as an immigrant who grew up in Ethiopia ...

Review the current Sanofi SA ADR (SNY:XNAS) dividend yield and history to decide if SNY is the best investment for you. SNY - Sanofi SA ADR Dividends | Morningstar Morningstar brands and products ...

Sanofi will hold a conference call with analysts and investors at 8:30 a.m. U.S. Eastern time on Friday. Shares in Sanofi are traded in the U.S. under the ticker symbol SNY.

Purpose— Much has transpired since the last scientific statement on pediatric stroke was published 10 years ago. Although stroke has long been recognized as an adult health problem causing substantial ...